Manuscript Submission

Manuscripts must be sent electronically using the editorial managing system which could be reached by clicking "ONLINE MANUSCRIPT SUBMISSION" button located on the home page or at

The submission fee is 50 $ (for foreign authors) and 450 TL (for Turkish authors) per article. This fee is separate from the article processing charge (APC) and will be collected by the contracted IT Company (Yazılım Parkı) as usage fee for the online article submission and tracking system. The submission fee can be paid by credit card online as the last step of the manuscript submission within online article submission and tracking system. The submission fee can also be paid by wire transfer. In this case, your article will be processed after the payment is received. You can find the bank account information for the wire transfer below. This fee will not be repaid if the article is rejected in any stage. Neither our journal nor our foundation has any legal or financial liability due to these fees.

Yazılım Parkı Payment Information for Wire Transfer / EFT:
Bank Name: Garanti BBVA (Branch Name: Birlik Şubesi)
Swift Code (BIC Code): TGBATRISXXX
for $ IBAN: TR83 0006 2001 1820 0009 0925 96
for TL IBAN: TR84 0006 2001 1820 0006 2977 17

On submission of the manuscript, the authors are required to fill in and sign the form "Acknowledgement of Authorship, Conflict of Interest Statement, and Transfer of Copyright Agreement". Authors should clearly state whether or not any conflict of interest issue exists, and state their contribution to the study.

An ORCID ID is required for all authors during the submission of the manuscript. The ID is available free of charge at

Editorial and Publication Policy and Process

The editorial and publication processes of the Journal are conducted in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The Journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (

Submitted material must be approved by the editorial board in order to be published. A peer review will be made by at least two reviewers, and the editorial board has the right to accept, ask for revision, or reject the manuscript. If the revised version of the manuscript is not submitted within the allocated time (30 days), the revision option may be cancelled. Once a manuscript is submitted, authors may not add, remove or change authors of the manuscript.

Reviewers are selected among independent experts who are experienced authors who have publications in the international literature. Manuscripts may be rejected without peer review by the editor-in-chief if they do not comply with the instructions to authors or if they are beyond the scope of the Journal. Any manuscript that does not conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as reported at will also be rejected. Following rejection, with or without peer review, no further details will be provided.

Manuscripts are scanned for plagiarism or duplication. In case of an ethical issue on plagiarism or duplication, the Editorial Board will act in accordance with the Committee on Publication Ethics (COPE). Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with similarity and without citation. If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s). The Journal uses plagiarism screening tool to screen all submissions and to verify the originality of content before publication.

Ethical Considerations

An approval of research protocols by the Ethics Committee in accordance with international agreements (Helsinki Declaration, revised 2013, Guide for the Care and Use of Laboratory Animals - is required for experimental, clinical, and investigational drug studies, and some case reports.

Ethics committee approval should be uploaded upon submission of an original research article. For research articles in humans or animals, the corresponding author must submit a copy of the approval by the institutional review board (IRB) and appropriate ethics committee. All articles studying human subjects must include a statement that the subjects gave informed consent to participate. For case reports and clinical pictures informed consent obtained from each patient and/or their families with the following statement is necessary; "The patients and/or their families were informed that data from the case would be submitted for publication and gave their consent." Please, do not use any identifying information.

In manuscripts reporting the results of an experimental study, it must be stated within the main text that all patients were informed in detail on the treatments and that an informed consent was obtained from each patient. For studies carried out on animals, the measures taken to prevent pain and suffering of the animals must be explicitly stated. Information on the patient consent, name of the ethics committee, and the ethics committee approval date and number must be stated in the Patients and Methods section of the manuscript. It is the author's responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patient, signed releases of the patient or of his/her legal representative must be enclosed. In case of an ethical issue on plagiarism or duplication, the Editorial Board will act in accordance with the Committee on Publication Ethics (COPE).

Article Processing Charge

Joint Diseases and Related Surgery is an open access journal and full texts of all published articles are freely available without embargo since 1990. All expenses and costs related to the journal are covered by article processing charges.


The authors with accepted articles for publication in the Journal will be required to make a financial contribution. This contribution share will be determined according to the number of pages which the articles cover in the Journal.

It will become:

186 € [Euro] (for foreign authors) per page which includes %20 VAT plus %25 at least other taxes.

3.987 TL (for Turkish authors with 33% reduction) per page which includes %20 VAT plus %25 at least other taxes.                    

Article Processing Charge may be regulated (increased or decreased) any time due to economic conditions.

Turkish Joint Diseases Foundation for publishing and other services:

Bank Account for FOREIGN authors:
Ziraat Bankasi Bilkent Plaza Ankara Subesi
[Euro] IBAN: TR81 0001 0017 6289 9775 4450 06
Swift code: TCZBTR2A
Payee’s name:
Turkiye Eklem Hastaliklari Tedavi Vakfi Iktisadi Isletmesi

Bank Account for TURKISH authors:
Ziraat Bankası Bilkent Plaza Ankara Şubesi
TL IBAN: TR38 0001 0017 6289 9775 4450 04
Payee’s name:
Türkiye Eklem Hastalıkları Tedavi Vakfı İktisadi İşletmesi

  • These fees are in no way related to the scientific evaluations conducted voluntarily by our journal’s editorial board and consultant referees.
  • Any rejected article has no competence or priority for our journal scientifically. No further details should be requested from us.